Home › Trial NCT00833326
A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer
- Trial IDNCT00833326
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorArray Biopharma, now a wholly owned subsidiary of Pfizer
- Enrollment27
- Start date2009-01
- ConditionsAdvanced Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.